Sawtooth Solutions, LLC Supernus Pharmaceuticals, Inc. Transaction History

Sawtooth Solutions, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 08, 2019	SELL	$29.96 - $38.87 $220,984 - $286,705	-7,376 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$32.77 - $41.99 $241,711 - $309,718	7,376 New	7,376 $258,000
Q4 2018 Feb 13, 2019	SELL	$30.84 - $49.51 $141,709 - $227,498	-4,595 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$42.7 - $56.55 $126,648 - $167,727	-2,966 Reduced 39.23%	4,595 $231,000
Q2 2018 Aug 10, 2018	BUY	$44.1 - $59.85 $333,440 - $452,525	7,561 New	7,561 $452,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Sawtooth Solutions, LLC with notifications on news.